Ingevity Corp. Files 8-K on Financials
Ticker: NGVT · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1653477
| Field | Detail |
|---|---|
| Company | Ingevity Corp (NGVT) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: NGVT
TL;DR
NGVT filed an 8-K on Aug 4, 2025, covering financial results. Check it for details.
AI Summary
On August 4, 2025, Ingevity Corp. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina.
Why It Matters
This filing provides investors with crucial updates on Ingevity Corp.'s financial performance and operational status, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Ingevity Corp. (company) — Registrant
- August 4, 2025 (date) — Date of Report
- 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Ingevity Corp.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on August 4, 2025.
What is Ingevity Corp.'s principal executive office address?
Ingevity Corp.'s principal executive office is located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.
What is Ingevity Corp.'s fiscal year end?
Ingevity Corp.'s fiscal year ends on December 31.
What is the SEC file number for Ingevity Corp.?
The SEC file number for Ingevity Corp. is 001-37586.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Ingevity Corp (NGVT).